Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile
Massimiliano di Pietro

@massi_dipietro

gastroenterologist, father, tennis player, scientist, Napoli S.S.C. fan, interventional endoscopist, football coach

ID: 2743790693

calendar_today15-08-2014 19:43:46

127 Tweet

243 Followers

103 Following

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

The boys are taking the challenge to run #raceforlife 10k to beat cancer . Please support them generously fundraise.cancerresearchuk.org/team/di-pietro…

Lovorka Stojic (@stojic_lovorka) 's Twitter Profile Photo

🚩The boys are running 10K #RaceForLife on 2nd July in Cambridge. Please support our challenge also this year so we can together beat cancer and raise as much as we can for Science and Innovation at Cancer Research UK Massimiliano di Pietro šŸ§ŖšŸƒā€ā™€ļøšŸ‘‡šŸ‘‡ fundraise.cancerresearchuk.org/team/di-pietro…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Running #RaceForLife for #CRUK WITH Lovorka Stojic and the boys. We need your support. This year 10k to push ourself (and the boys) further. Your support will be greatly appreciated fundraise.cancerresearchuk.org/team/di-pietro…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

2nd Upper GI Endoscopy Education & Training Day Nottingham Great preseantation from Nigel Trudgill Post Endoscopy upper GI cancer rate in UK 8.5% Factor associated: - Young age - Female OR 1.3 (mostly oesophageal) - Lack of alarm symptoms - High comorbs score

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Very good results from Rebecca Fitzgerald Lab at Early Cancer Institute, University of Cambridge Barrett’s with gastric metaplasia only does not progress to cancer and has low mutational burden. Time to discharge these patients from regular follow up. gut.bmj.com/content/early/…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

I am running in just over a week the Cambridge Half Marathon. I am raising money for the Addenbrookes Charitable Trust. Please visit my home page to make this run even more worthwhile for all those who need their support. Thanks! justgiving.com/page/massimili…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

I’m fundraising for Addenbrooke's Charitable Trust. Check out my JustGiving page and please donate if you can. Thank you! #JustGiving justgiving.com/page/massimili…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Feeling quite excited for the Cambridge Half Marathon tomorrow and my fundraising for the Addenbrooke’s Charitable Trust. Check out my JustGiving page and please donate if you can. Thank you! #JustGiving justgiving.com/page/massimili…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Glad to see the #barrett’s oesophagus NICE guidelines published in Gut. Practical and evidence based document to inform best practice pubmed.ncbi.nlm.nih.gov/38553042/

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

It’s that time of the year we come together as family to run against cancer. Help us support Cancer Research UK! fundraise.cancerresearchuk.org/team/family-te…

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Really excited for tomorrows family Race for Life 2024! Please support #CRUK with a donation here . 4x 10km against cancer fundraise.cancerresearchuk.org/team/family-te…

Heartburn Cancer UK (@heartburncancer) 's Twitter Profile Photo

Still time to book… On 26th September- 6pm @rfitzgerald_lab - our charity medical trustee will host the East Anglia Support Group's Annual Online Event - "Caring for Patients with Heartburn & Barrett's" To find out more & book a place click here - i.mtr.cool/vrmvzsevyu

Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Rob Odze at #ISDE2024 : we should abandon LGD / HGD classification in Barrett’s Esophagus . Foveolar dysplasia (no IM) has the highest cancer risk. The grade of baseline Atypia also matter

Rob Odze at #ISDE2024 : we should abandon LGD / HGD classification in Barrett’s Esophagus . Foveolar dysplasia (no IM) has the highest cancer risk. The grade of baseline Atypia also matter
Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

David Liu at #ISDE2024 from SPACE-FLOT study: adjuvant FLOT does not confer survival benefit in those with pCR and poor response to neo-adjuvant FLOT. It does only in those partial response.

David Liu at #ISDE2024 from SPACE-FLOT study: adjuvant FLOT does not confer survival benefit in those with pCR and poor response to neo-adjuvant FLOT. It does only in those partial response.
Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

Daniela Moena at #ISDE2024 from Matterhorn trial: higher rate of pathological complete response in Durvalumab + FLOT compared to FLOT alone. Awaiting PFS data, great promise

Daniela Moena at #ISDE2024 from Matterhorn trial: higher rate of pathological complete response in Durvalumab + FLOT compared to FLOT alone. Awaiting PFS data, great promise
Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

The 13th Cambridge Upper GI symposium has just finished. What a couple of days of lectures, research talks and stimulating debates. Thanks to the faculty for participating and educating a thrilled audience

The 13th Cambridge Upper GI symposium has just finished. What a couple of days of lectures, research talks and stimulating debates. Thanks to the faculty for participating and educating a thrilled audience
Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

The results of the BOSS trial -2 y Barrett’s surveillance vs endoscopy at need- presented for the first time at the 13th Cambridge UGI symposium - no difference in cancer mortality but disappointingly more than 50% of OAC diagnosed in surveillance >T1. Time for a rethink

The results of the BOSS trial -2 y Barrett’s surveillance vs endoscopy at need- presented for the first time at the 13th Cambridge UGI symposium - no difference in cancer mortality but disappointingly more than 50% of OAC diagnosed in surveillance >T1. Time for a rethink
Massimiliano di Pietro (@massi_dipietro) 's Twitter Profile Photo

We have a fantastic clinical research fellow job opportunity in Cambridge working on novel imaging modalities for early cancer detection and training in advanced endoscopic imaging and therapeutic. This is funded by the OASIS resaerch consortium jobs.cam.ac.uk/job/51736/